A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these accounts privately for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid British shipping. Vendors market the drug there before redirecting customers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could result in individuals administering substances of uncertain source.
Several experts said the demand for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.
Service Reaction and Content Elimination
According to TikTok, the service has removed problematic material and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.
Digital Trading Operations
Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with images of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at home.
After moments of entering one community, a seller shared WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.
Product Information and Costs
Inside these communities, messages display dark colored packages with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.
Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject users to potentially significant health risks”.
